PTC Therapeutics Stock Price. Everything You Need To Know About The PTC Therapeutics Stock!
PTC Therapeutics, Inc. is a science-driven, global biopharmaceutical company. The Company is focused on the discovery, development and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. Its portfolio pipeline includes several commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology, metabolism and oncology. The Company has two products, Translarna (ataluren) and Emflaza (deflazacort), for the treatment of Duchenne muscular dystrophy (DMD). It also offers Upstaza, a gene therapy for the treatment of Aromatic L-Amino Decarboxylase (AADC) deficiency, and Evrysdi, a treatment for spinal muscular atrophy (SMA). Its splicing platform includes PTC518, which is being developed for the treatment of Huntington’s disease (HD).
PTC Therapeutics Stock Price. Everything You Need To Know About The PTC Therapeutics Stock! performance
- Employees 1402
- Company HQ South Plainfield
- Website https://www.ptcbio.com/
- PTCT Asset Type Common Stock
- PTCT Market Capitalization 2.5B
- Earnings Per Share -7.69
- Dividends Per Share None
- Dividend Date None
- Quarterly Earnings Growth 0
Are you interested in investing in the healthcare industry? PTC Therapeutics, a leading biopharmaceutical company based in the United States, presents an exciting opportunity for investors from Malaysia, Thailand, Indonesia, and Vietnam. With Zorion, a trusted investment platform, you can now easily invest in PTC Therapeutics and take advantage of its potential growth. PTC Therapeutics focuses on the development and commercialization of innovative therapies for rare genetic diseases. By investing in PTC Therapeutics, you not only have the chance to support groundbreaking medical advancements but also to potentially reap significant returns. Zorion provides investment insights and recommendations, as well as educational resources to help you make informed decisions about investing in PTC Therapeutics. Start investing today and be a part of the future of healthcare.
